{
    "pmcid": "11466415",
    "qa_pairs": {
        "What future direction does the study suggest for improving the design of TCRs and nanobodies using ESM-IF1?": [
            "Integrating ESM-IF1 with other computational tools to refine designs and assess cross-reactivity potential.",
            "Focusing solely on increasing the dataset size for training ESM-IF1.",
            "Developing a new version of ESM-IF1 specifically for oligomeric interfaces.",
            "Applying ESM-IF1 exclusively to non-viral antigens to avoid cross-reactivity."
        ],
        "What is a challenge mentioned in the study regarding the use of ESM-IF1 for therapeutic applications?": [
            "Ensuring specificity and minimizing cross-reactivity of designed binders.",
            "Improving the speed of sequence recovery.",
            "Reducing the computational cost of the model.",
            "Increasing the dataset size for training the model."
        ],
        "What is one of the key insights regarding the ESM-IF1 model's potential application beyond TCR design?": [
            "It can be used to design nanobody binders for SARS-CoV-2 with high affinity and specificity.",
            "It is primarily effective only for single-chain protein structures.",
            "It is limited to designing proteins with known oligomeric interfaces.",
            "It cannot be applied to viral antigen design due to specificity issues."
        ],
        "What is the primary focus of the paper titled 'Exploring the potential of structure-based deep learning approaches for T cell receptor design'?": [
            "Investigating the application of deep learning models for designing T cell receptors that bind to antigenic peptides presented by the MHC.",
            "Exploring the use of deep learning models for predicting protein folding pathways.",
            "Developing new algorithms for improving the speed of protein structure prediction.",
            "Analyzing the effects of mutations on the stability of T cell receptors."
        ],
        "Which deep learning model demonstrated higher sequence recovery rates compared to ProteinMPNN and Rosetta Design in the study?": [
            "ESM-IF1",
            "AlphaFold2",
            "DeepMind's ProteinNet",
            "Rosetta Design"
        ]
    }
}